Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Issue Archive

Table of Contents

CLINICAL GUIDELINES

EXCEPTIONAL CASE REPORT

STIMULUS REPORT

SYSTEMATIC REVIEW

CLINICAL TRIALS AND OBSERVATIONS

Isamu Sugiura,on behalf of the Japan Adult Leukemia Study Group,Noriko Doki,on behalf of the Japan Adult Leukemia Study Group,Tomoko Hata,on behalf of the Japan Adult Leukemia Study Group,Ryuko Cho,on behalf of the Japan Adult Leukemia Study Group,Toshiro Ito,on behalf of the Japan Adult Leukemia Study Group,Youko Suehiro,on behalf of the Japan Adult Leukemia Study Group,Masatsugu Tanaka,on behalf of the Japan Adult Leukemia Study Group,Shinichi Kako,on behalf of the Japan Adult Leukemia Study Group,Mitsuhiro Matsuda,on behalf of the Japan Adult Leukemia Study Group,Hisayuki Yokoyama,on behalf of the Japan Adult Leukemia Study Group,Yuichi Ishikawa,on behalf of the Japan Adult Leukemia Study Group,Yasuhiro Taniguchi,on behalf of the Japan Adult Leukemia Study Group,Maki Hagihara,on behalf of the Japan Adult Leukemia Study Group,Yukiyasu Ozawa,on behalf of the Japan Adult Leukemia Study Group,Yasunori Ueda,on behalf of the Japan Adult Leukemia Study Group,Daiki Hirano,on behalf of the Japan Adult Leukemia Study Group,Toru Sakura,on behalf of the Japan Adult Leukemia Study Group,Masaaki Tsuji,on behalf of the Japan Adult Leukemia Study Group,Tsuyoshi Kamae,on behalf of the Japan Adult Leukemia Study Group,Hiroyuki Fujita,on behalf of the Japan Adult Leukemia Study Group,Nobuhiro Hiramoto,on behalf of the Japan Adult Leukemia Study Group,Masahiro Onoda,on behalf of the Japan Adult Leukemia Study Group,Shin Fujisawa,on behalf of the Japan Adult Leukemia Study Group,Yoshihiro Hatta,on behalf of the Japan Adult Leukemia Study Group,Nobuaki Dobashi,on behalf of the Japan Adult Leukemia Study Group,Satoshi Nishiwaki,on behalf of the Japan Adult Leukemia Study Group,Yoshiko Atsuta,on behalf of the Japan Adult Leukemia Study Group,Yukio Kobayashi,on behalf of the Japan Adult Leukemia Study Group,Fumihiko Hayakawa,on behalf of the Japan Adult Leukemia Study Group,Shigeki Ohtake,on behalf of the Japan Adult Leukemia Study Group,Tomoki Naoe,on behalf of the Japan Adult Leukemia Study Group,Yasushi Miyazaki,on behalf of the Japan Adult Leukemia Study Group

IMMUNOBIOLOGY AND IMMUNOTHERAPY

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

THROMBOSIS AND HEMOSTASIS

TRANSPLANTATION

RESEARCH LETTER

COMMENTARY

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals